Home > Press > NanoInk installs new nanofabrication system at the University of Strathclyde’s Centre for Molecular Nanometrology
The NanoInk DPN 5000 system |
Abstract:
Professor Duncan Graham and his research group at The Centre for Molecular Nanometrology at the University of Strathclyde has taken delivery of the DPN 5000 nanolithography tool, NanoInk's latest high precision Dip Pen Nanolithography® (DPN®) system.
Combining high resolution lithography with world class imaging capability, the new instrument will expand the group's already formidable nanotechnology toolkit and help Graham move towards in vivo imaging approaches based on functional nanoparticles and SERS analysis.
Professor Graham is a recognized leader in the field of Surface Enhanced Raman Spectroscopy (SERS) and an early adopter of DPN technology, driven by the ability of NanoInk's instrumentation to place nanoscale features directly onto existing microstructures. The SERS substrate, Klarite®, is an array of gold-coated, microscale inverted pyramids designed to provide more consistent SERS data. Graham has demonstrated NanoInk's unique ability to precisely and controllably deposit materials to the individual pyramids. This combination of DPN and SERS is one of the few ways of extracting spectroscopic data from nanoscale patterns.
Following this early success with DPN, Graham's lab is applying NanoInk's instruments to the group's other research interests. For example, they are now using the NLP 2000 to create large area nanoscale arrays of biomolecules, nanoparticles and SAM molecules. The team has shown that they can fabricate highly sensitive protein assays, ultimately leading to the development of new devices that could revolutionize the detection of cancer biomarkers.
To learn more about DPN, its application and instrumentation platforms, please visit www.nanonink.net.
####
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop.
Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., see www.nanonink.net
NanoInk, the NanoInk logo, Dip Pen Nanolithography, and DPN are trademarks or registered trademarks of NanoInk, Inc. Klarite is a trademark belonging to D3 Technologies Limited, Scotland.
For more information, please click here
Contacts:
Jezz Leckenby
NetDyaLog
T: +44 (0) 1799 521881
M: +44 (0) 7843 012997
Sarah Kosar Raup
NanoInk
T: +1 847 745 3619
Copyright © NanoInk
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||